ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 89 filers reported holding ARATANA THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $21,248 | -79.7% | 4,118 | -75.8% | 0.00% | -100.0% |
Q4 2018 | $104,455 | +5.0% | 17,040 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $99,514 | +1321.6% | 17,040 | +1104.2% | 0.00% | – |
Q4 2017 | $7,000 | -96.2% | 1,415 | -95.3% | 0.00% | -100.0% |
Q3 2017 | $186,000 | -15.5% | 30,359 | -0.3% | 0.00% | -50.0% |
Q2 2017 | $220,000 | +61.8% | 30,449 | +18.9% | 0.00% | +100.0% |
Q1 2017 | $136,000 | -12.8% | 25,619 | +17.9% | 0.00% | 0.0% |
Q4 2016 | $156,000 | -26.8% | 21,736 | -4.4% | 0.00% | -50.0% |
Q3 2016 | $213,000 | +31.5% | 22,738 | -11.6% | 0.00% | +100.0% |
Q2 2016 | $162,000 | -7.4% | 25,709 | +24.3% | 0.00% | 0.0% |
Q3 2015 | $175,000 | -42.6% | 20,686 | +2.6% | 0.00% | -50.0% |
Q2 2015 | $305,000 | -3.8% | 20,168 | +1.8% | 0.00% | 0.0% |
Q1 2015 | $317,000 | -19.5% | 19,810 | -10.5% | 0.00% | -33.3% |
Q4 2014 | $394,000 | +100.0% | 22,138 | +12.8% | 0.00% | +200.0% |
Q3 2014 | $197,000 | -35.6% | 19,624 | 0.0% | 0.00% | -50.0% |
Q2 2014 | $306,000 | – | 19,624 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
March Altus Capital Management LP | 218,515 | $1,219,000 | 11.21% |
Broadfin Capital, LLC | 3,428,865 | $19,133,000 | 1.18% |
MPM ASSET MANAGEMENT LLC | 1,117,875 | $6,238,000 | 1.11% |
AlpInvest Partners B.V. | 100,001 | $558,000 | 0.93% |
First Light Asset Management, LLC | 395,043 | $2,204,000 | 0.92% |
Westend Capital Management, LLC | 89,780 | $501,000 | 0.69% |
Grandeur Peak Global Advisors, LLC | 460,675 | $2,571,000 | 0.53% |
AWM Investment Company, Inc. | 467,507 | $2,609,000 | 0.51% |
HAMILTON LANE ADVISORS LLC | 111,705 | $623,000 | 0.27% |
Sio Capital Management, LLC | 97,376 | $543,000 | 0.24% |